Hjem › Myasthenia gravis › Michigan
Kliniske studier for Myasthenia gravis i Michigan
12 studier for Myasthenia gravis søker deltakere på steder i Michigan.
Byer i Michigan
Offisiell studietekst (engelsk)
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Henry Ford Hospital, Detroit
RekruttererFase 3
Alder 18 til 74 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07217587ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Henry Ford Health System, Detroit
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07294170ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Henry Ford Health Systems, Detroit
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07284420A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
- TG Therapeutics Investigational Trial Site, Farmington Hills
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07673744A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Ann Arbor
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06680037Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Dearborn
- Aurinia Investigational Site, Flint
RekruttererFase 1/2
Alder 18 til 85 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT07596901A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
- C.S. Mott Children's Hospital, Ann Arbor
RekruttererFase 2/3
Alder 2 til 17 · Alle kjønn · Oppdatert 31. jul. 2026 · NCT05265273Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1026, Detroit
- Site Number - 1005, East Lansing
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 30. jul. 2026 · NCT07039916A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Michigan State University Clinical Center, East Lansing
- Trinity Health - Grand Rapids Hospital, Grand Rapids
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. jun. 2026 · NCT06456580A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Karmanos Cancer Institute, Detroit
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 25. feb. 2026 · NCT06626919Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Lansing
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 18. feb. 2026 · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Henry Ford Health System, Detroit
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 17. feb. 2026 · NCT06298565Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.